pd-y-64

Drug Delivery Devices

Drug delivery devices for injectable drugs can provide precise and controlled dosing, bypassing gastrointestinal barriers, and can provide rapid onset of action for some applications. Drug delivery devices are also important as they can provide targeted local delivery as they can enable emergency treatments or even self-administered home care. Terumo Medical Care Solutions – Pharmaceutical develops and manufactures innovative parenteral drug delivery devices for the unique needs of pharmaceutical and biotech companies and their patients.
text-vertical-center
image-media-type
TBD
media-right
true
pd-y-64
section-colour
section-bg-linear-gradient
Terumo Pharmaceutical Solutions: Advancing Drug Delivery Device Technology
  • Immucise™ Intradermal Injection System
    The Immucise™ Intradermal Injection System is indicated for intradermal injections of FDA approved drugs*. The system is to be used in the deltoid region for infants aged two months (excluding low birth weight and/or preterm birth) to adults. The needle of Immucise™ is designed to the proper size to retain the needle tip in the dermal layer of the skin2 .
    *For other territories, Immucise™ Intradermal Injection System is intended to be used for the intradermal injection of approved formulations
normal
pd-y-64
variation-1
cards-3
white-bg
false
variation-1-card
image
TBD
Immucise™ Intradermal Injection System
Drug Delivery Devices
Terumo’s Immucise™ Intradermal Injection System is designed to deliver vaccines and other approved drugs to the dermal layer of the skin for improved immune response in comparison to intramuscular or subcutaneous injections1 . The vertical type intradermal (ID) injection system is applied perpendicular to the skin of the deltoid region of the patient’s arm2 .
View Product
View Product
/content/psd-ia/en/products/drug-delivery-devices/immucise
link
pd-y-64
section-colour
section-bg-light-grey

References

1. Intradermal Delivery of Vaccines, A review of the literature and the potential for development for use in low- and middle-income countries, August 27, 2009

2. Shimizu, Sakiko et al. “Performance and usability evaluation of novel intradermal injection device Immucise™ and reanalysis of intradermal administration trials of influenza vaccine for the elderly.” Vaccine vol. 40,6 (2022): 873 -879

#444B52
pd-y-64
pd-y-32
Looking for another Terumo Pharmaceutical Solutions product?
3
neutrals-100
Explore our portfolio of infusion and injection technologies to discover the full range of patient focused healthcare solutions available from Terumo Pharmaceutical Solutions.
#444B52
View All Products
View All Products
/content/psd-ia/en/products
button psd-primary
pd-y-64
pd-y-64

Connect with Our Drug Delivery Device Experts

Terumo Pharmaceutical Solutions helps to bring medical innovations to life. Reach out to our drug delivery device experts today, to discuss how we can support your parenteral drug delivery needs.
Contact Us
Contact Us
/content/psd-ia/en/contact
button psd-primary
text-vertical-center
image-media-type
TBD
true
pd-y-64